These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5495393)

  • 1. The nephrotic syndrome as a complication of gold therapy.
    Vaamonde CA; Hunt FR
    Arthritis Rheum; 1970; 13(6):826-34. PubMed ID: 5495393
    [No Abstract]   [Full Text] [Related]  

  • 2. Gold nephropathy. A clinical and pathologic study.
    Silverberg DS; Kidd EG; Shnitka TK; Ulan RA
    Arthritis Rheum; 1970; 13(6):812-25. PubMed ID: 5495392
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nephropathy in rheumatoid arthritis treated with gold preparations].
    Polianskaia IP; Beresten' TI
    Ter Arkh; 1978; 50(6):96-9. PubMed ID: 675544
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotic syndrome induced by gold therapy.
    Wilkinson R; Eccleston DW
    Br Med J; 1970 Jun; 2(5712):772. PubMed ID: 5428742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nephrotic syndrome due to gold salts (apropos of 4 cases)].
    Renier JC; Boasson M; Bernat M; Fressinaud P
    Sem Hop; 1973 Mar; 49(12):881-9. PubMed ID: 4352984
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal vein thrombosis associated with nephrotic syndrome and gold therapy in rheumatoid arthritis.
    Nelson DC; Birchmore DA
    South Med J; 1979 Dec; 72(12):1616-8. PubMed ID: 515782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold nephropathy in rheumatoid arthritis and in juvenile chronic arthritis.
    Rovenská E; Kapeller K; Rossmann P
    Czech Med; 1979; 2(3):125-33. PubMed ID: 535499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced nephropathies.
    Burry HC
    Proc R Soc Med; 1973 Sep; 66(9):897-900. PubMed ID: 4805093
    [No Abstract]   [Full Text] [Related]  

  • 9. Gold nephropathy. An immunopathologic study.
    Katz A; Little AH
    Arch Pathol; 1973 Aug; 96(2):133-6. PubMed ID: 4198015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrotic syndrome through extramembranous glomerulonephritis induced by levamisole in a patient with rheumatoïd arthritis].
    Menkes CJ; Feldmann JL; Baptiste GJ; Delbarre F
    Nouv Presse Med; 1978 Sep; 7(30):2654-5. PubMed ID: 693304
    [No Abstract]   [Full Text] [Related]  

  • 11. Gold-induced immune complex nephritis in seronegative rheumatoid arthritis.
    Skrifvars BV; Törnroth TS; Tallqvist GN
    Ann Rheum Dis; 1977 Dec; 36(6):549-56. PubMed ID: 145832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simultaneous nephropathy, lung disease and liver disease caused by gold salts, with an ultrastructural study of pulmonary and renal lesions].
    Alcalay M; Touchard G; Patte F; Babin P; Reboux JF; Thomas P; Patte D; Bontoux D
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):491-8. PubMed ID: 504952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prolonged gold therapy for nephrotic syndrome in a patient with undiagnosed polyarthritis].
    Leszczyński P; Mackiewicz SH
    Pol Arch Med Wewn; 1996 Aug; 96(2):153-6. PubMed ID: 9122003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold-associated nephropathy.
    Francis KL; Jenis EH; Jensen GE; Calcagno PL
    Arch Pathol Lab Med; 1984 Mar; 108(3):234-8. PubMed ID: 6365028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis.
    Yoshida A; Morozumi K; Suganuma T; Sugito K; Ikeda M; Oikawa T; Fujinami T; Takeda A; Koyama K
    Am J Nephrol; 1991; 11(4):284-8. PubMed ID: 1799186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous nephropathy in rheumatoid arthritis.
    Figueroa JE; Waxman J
    South Med J; 1982 Apr; 75(4):480-2. PubMed ID: 7071645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome with reversible severe renal failure after gold therapy.
    Blum M; Liron M; Aviram A
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):562-4. PubMed ID: 6511133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conspicuous accumulation of membranous glomerulonephritis following gold therapy in chronic polyarthritis--a side effect of a new preparation?].
    Burger HR; Briner J; Spycher MA
    Schweiz Med Wochenschr; 1979 Mar; 109(12):423-31. PubMed ID: 106466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undesirable effects of gold salts.
    Davis P
    J Rheumatol Suppl; 1979; 5():18-24. PubMed ID: 290813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.